Innovation Pharmaceuticals Inc (CTIX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access CTIX Annual Balance Sheets →
Changes in quarterly balance sheet trends offer perspective on how Innovation Pharmaceuticals Inc balances growth, leverage, and shareholder equity.
Quarterly Report, GAAP in USD millions
ITEM
(Sep 30 2023)
(Jun 30 2023) (Mar 31 2023) (Dec 31 2022) (Sep 30 2022)
Assets
Cash & cash equivalent0.86
Security Deposit0.08
Cash & Short-term Investments0.00
Prepaid Expense And Other Assets Current0.08
Total Current Assets1.02
Intangible Assets1.91
Long-term investments3.74
Other Assets, Noncurrent1.00
Equity Method Investment0.00
Patents Net-
Patents Net-
Total Assets6.67
Liabilities
Accounts Payable, Current AC3.02
Accrued Liabilities, Current AC0.19
Convertible Notes Payable, Current NO0.00
Other Liabilities, Current1.84
Total Current Liabilities5.05
Convertible Notes Payable NO0.24
Total Long-term Debt0.24
Other liabilities, Noncurrent0.22
Accrued Dividend Series B Five Convertibles Preferred Stock0.01
Operating Lease Liability Current0.00
Total Liabilities5.51
Stockholders' Equity
Common Stock Value0.00
Treasury Stock Value-2.25
Additional Paid In Capital Common Stock129.57
Retained Earnings / Accumulated Deficit-126.21
Other Equity0.05
Common Stockholder's Equity1.16
Total Stockholder's Equity1.16
Liabilities & Stockholder's Equity6.67
4 historic quarters locked

Sign in to unlock the full Innovation Pharmaceuticals Inc balance sheet history.

About Innovation Pharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001477932-23-008688

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.